Feasibility of modulated electro-hyperthermia in preoperative treatment for locally advanced rectal cancer: Early phase 2 clinical results

overall preoperative treatment outline

Feasibility of modulated electro-hyperthermia in preoperative treatment for locally advanced rectal cancer: Early phase 2 clinical results Contact Us Summary A prospective trial was conducted to see if modulated electro-hyperthermia (mEHT) might be used as a boost to preoperative chemoradiation in patients with locally advanced rectal cancer. With the addition of mEHT, a relatively low […]

Successful alternative treatment for relapsed adult Acute Lymphoblastic Leukemia with Dendritic Cells- Cytokine-Induced Killer Cells combined with a rituximab-based regimen

Change in expression

Successful alternative treatment for relapsed adult Acute Lymphoblastic Leukemia with Dendritic Cells- Cytokine-Induced Killer Cells combined with a rituximab-based regimen Contact Us Summary This study investigates the efficacy and safety of DC-CIK for patients with Acute lymphoblastic leukemia (ALL) that are unable to tolerate chemotherapy. The results suggests , relapsed ALL was successfully treated with […]

Clinical efficacy of DC-CIK combined with sorafenib in the treatment of advanced hepatocellular carcinoma

Overall Survival

Clinical efficacy of DC-CIK combined with sorafenib in the treatment of advanced hepatocellular carcinoma Contact Us Summary The aim of this study is to explore the efficacy and safety of the combination treatment of dendritic cells and cytokine-induced killers (DC-CIK) and sorafenib in patients with advanced hepatocellular carcinoma (HCC).DC-CIK combined with sorafenib could improve the […]

Efficacy analysis of triple-negative breast cancer patients treated with dendritic cell-cytokine-induced killer cell immunotherapy

Overall Survival

Efficacy analysis of triple-negative breast cancer patients treated with dendritic cell-cytokine-induced killer cell immunotherapy Contact Us Summary The study investigates the efficacy of dendritic cell-cytokine-induced killer (DC-CIK) cell immunotherapy combined with chemotherapy with or without radiotherapy for triple-negative breast cancer (TNBC) patients followingsurgery. The results suggest the patients may benefit from an adjuvant infusion of […]